Clinic News

Latest in Cardiology

• Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure
  The goal of the PARADIGM-HF trial was to evaluate treatment with the combined neprilysin inhibitor (sacubitril)/angiotensin-receptor blocker (valsartan) (LCZ696) compared with enalapril among participants with heart failure due to reduced ejection fraction (EF).
• Impact of Cardiovascular Risk Factors and Genetics on 10-Year Risk of Dementia
  What socioeconomic, genetic, and modifiable risk factors best predict development of dementia?
• Features of Patients With Out-of-Hospital Cardiac Arrest and Acute MI
  What are clinical and angiographic characteristics of patients with acute myocardial infarction (MI) and out-of-hospital cardiac arrest (OHCA)?
• Proteomic Signatures of Heart Failure in Relation to LVEF
  Do proteomic profiles differ between patients with heart failure and reduced ejection fraction (HFrEF), HF with midrange EF (HFmrEF), and HF with preserved EF (HFpEF)?
• ACCEL Lite: The Effects of Early Rhythm Control Therapy in Patients With AF
  In this interview, Freek Verheugt and Paulus Kirchhof discuss EAST-AFNET 4: Effects of Early Rhythm Control Therapy in Patients with Atrial Fibrillation from ESC Congress 2020. The results of EAST-AFNET 4 could redefine the role of rhythm control therapy for improved outcomes in patients with early atrial fibrillation.
• Prevention of Heart Failure in Type 2 Diabetes Mellitus – The Importance of Lifestyle
  Type 2 diabetes mellitus (T2DM) affects approximately 10% of adults in the United States, accounts for $327 billion of annual costs, and is associated with increased risk of cardiovascular disease.
• Plasma ACE2 and Risk of Death or Cardiometabolic Diseases
  Are plasma angiotensin-converting enzyme 2 (ACE2) concentrations associated with risk of death or cardiovascular (CV) events?
• Immune Checkpoint Inhibitors, Atherosclerosis, and Cardiovascular Events
  Are immune checkpoint inhibitors (ICI) associated with an increased risk of cardiovascular events and accelerated atherosclerosis?
• Echo Findings in Pediatric Multisystem Inflammatory Syndrome in COVID-19
  What are the echocardiographic manifestations of multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19), as compared to classic Kawasaki disease (KD)?
• JACC Series Looks at COVID-19 and CVD, Myocardial Injury, Arrhythmias and Cardiometabolic Syndrome
  Since the emergence of the COVID-19 pandemic, the impact of the virus on the heart has become more prevalent, with clinicians acting in real time to effectively help cardiovascular disease patients and those at higher risk who contract coronavirus. The Journal of the American College of Cardiology published a three-part focus seminar Oct. 19 on […]